RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 78 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,712,435 | +120.1% | 406,662 | +154.4% | 0.02% | +142.9% |
| Q4 2022 | $1,232,312 | +3.8% | 159,833 | +43.3% | 0.01% | 0.0% |
| Q3 2022 | $1,187,000 | +521.5% | 111,575 | +376.7% | 0.01% | +600.0% |
| Q2 2022 | $191,000 | -69.9% | 23,408 | -73.6% | 0.00% | -80.0% |
| Q1 2022 | $635,000 | +9.7% | 88,748 | +162.7% | 0.01% | -16.7% |
| Q4 2021 | $579,000 | -9.1% | 33,777 | +22.0% | 0.01% | -25.0% |
| Q3 2021 | $637,000 | +28.4% | 27,686 | +103.6% | 0.01% | +33.3% |
| Q2 2021 | $496,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |